Related Experiment Video
Updated: Dec 23, 2025
Bio-inspired Polydopamine Surface Modification of Nanodiamonds and Its Reduction of Silver Nanoparticles
Published on: November 14, 2018
Nanoparticles modified by polydopamine: Working as "drug" carriers.
Anting Jin1, Yitong Wang1, Kaili Lin1
1Department of Oral & Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Oral Diseases, Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, Shanghai, 200011, PR China.
Polydopamine (PDA)-modified nanoparticles offer versatile drug delivery solutions. These nanoparticles show promise in cancer therapy, tissue repair, and diagnostics due to their unique adhesive and therapeutic properties.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Polymer Chemistry
Background:
- Polydopamine (PDA) is a versatile polymer inspired by mussel adhesion.
- PDA exhibits excellent adhesiveness, biocompatibility, and unique functional properties.
- PDA-modified nanoparticles are increasingly explored as advanced drug carriers.
Purpose of the Study:
- To review recent advancements in PDA-modified nanoparticle drug carriers.
- To highlight their applications in various biomedical fields, particularly cancer therapy.
- To discuss preparation strategies, drug loading, and future trends.
Main Methods:
- Literature review of recent progress in PDA-modified nanoparticle drug carriers.
- Analysis of synthesis methods, nanostructures, and drug loading strategies.
- Examination of PDA's role in enhancing nanoparticle functionalities.
Main Results:
- PDA-modified nanoparticles demonstrate multifunctionality, including targeting, imaging, and various therapeutic modalities (CT, PDT, PTT).
- These nanoparticles are effective in cancer therapy, antibiosis, inflammation prevention, theranostics, vaccine delivery, tissue repair, and implant materials.
- PDA surface modification offers advantages in overcoming existing limitations in these applications.
Conclusions:
- PDA-modified nanoparticles represent a promising platform for diverse biomedical applications.
- Their unique properties facilitate advancements in drug delivery, cancer treatment, and regenerative medicine.
- Future research directions focus on optimizing PDA nanoparticle design and therapeutic efficacy.
